目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 UNIT CONSIDERED
1.6 KEY STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key secondary sources
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
2.2.1.2 Approach 2: Presentations of companies and primary interviews
2.2.1.3 Growth forecast
2.2.1.4 CAGR projections
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 MARKET SHARE ASSESSMENT
2.5 RESEARCH ASSUMPTIONS
2.5.1 PARAMETRIC ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 BURN CARE MARKET OVERVIEW
4.2 BURN CARE MARKET, BY PRODUCT, 2025 VS. 2030
4.3 BURN CARE MARKET, BY BURN DEGREE, 2025 VS. 2030
4.4 BURN CARE MARKET, BY END USER, 2025 VS. 2030
4.5 BURN CARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising incidence of burn injuries
5.2.1.2 Advancements in burn care products
5.2.1.3 Rising government and industry initiatives
5.2.1.4 Growing use of regenerative medicine for wound management
5.2.2 RESTRAINTS
5.2.2.1 High cost of advanced burn care treatments
5.2.2.2 Risks associated with use of advanced burn care products
5.2.3 OPPORTUNITIES
5.2.3.1 High growth opportunities in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Availability of alternative therapies
5.3 PRICING ANALYSIS
5.3.1 INDICATIVE SELLING PRICE TREND, BY PRODUCT
5.3.2 INDICATIVE SELLING PRICE TREND OF ADVANCED BURN DRESSINGS, BY KEY PLAYER
5.3.3 INDICATIVE SELLING PRICE TREND OF BURN CARE PRODUCTS, BY REGION
5.4 PATENT ANALYSIS
5.4.1 LIST OF MAJOR PATENTS
5.5 VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.7 TRADE ANALYSIS
5.7.1 IMPORT DATA (HS CODE 3005)
5.7.2 EXPORT DATA (HS CODE 3005)
5.8 ECOSYSTEM ANALYSIS
5.8.1 ROLE IN ECOSYSTEM
5.9 PORTER'S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF BUYERS
5.9.4 BARGAINING POWER OF SUPPLIERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 KEY STAKEHOLDERS & BUYING CRITERIA
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.10.2 BUYING CRITERIA
5.11 REGULATORY ANALYSIS
5.11.1 REGULATORY LANDSCAPE
5.11.1.1 North America
5.11.1.1.1 US
5.11.1.1.2 Canada
5.11.1.2 Europe
5.11.1.2.1 Germany
5.11.1.2.2 UK
5.11.1.2.3 France
5.11.1.2.4 Italy
5.11.1.3 Asia Pacific
5.11.1.3.1 China
5.11.1.3.2 Japan
5.11.1.3.3 India
5.11.1.4 Latin America
5.11.1.5 Middle East
5.11.1.5.1 Africa
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2.1 North America
5.11.2.2 Europe
5.11.2.3 Asia Pacific
5.11.2.4 Latin America
5.11.2.5 Rest of the World
5.12 TECHNOLOGY ANALYSIS
5.12.1 KEY TECHNOLOGIES
5.12.1.1 Negative-pressure wound therapy (NPWT)
5.12.2 COMPLEMENTARY TECHNOLOGIES
5.12.2.1 Burn wound assessment devices
5.12.3 ADJACENT TECHNOLOGIES
5.12.3.1 Debridement devices
5.13 KEY CONFERENCES & EVENTS, 2025-2026
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.15 INVESTMENT & FUNDING SCENARIO
5.16 CASE STUDY ANALYSIS
5.16.1 CASE STUDY 1: MANAGEMENT OF LARGE SURFACE AREA BURNS WITH GRAFTS OF SELF-ALLOGENEIC SKIN
5.16.2 CASE STUDY 2: EFFECTIVE MANAGEMENT OF SUPERFICIAL PARTIAL-THICKNESS BURNS USING ANTIMICROBIAL DRESSINGS
5.17 IMPACT OF AI ON BURN CARE MARKET
5.17.1 INTRODUCTION
5.17.2 MARKET POTENTIAL OF AI
5.17.3 AI USE CASES
5.17.4 KEY COMPANIES IMPLEMENTING AI
5.17.5 FUTURE OF AI IN BURN CARE MARKET
5.18 US BURN CARE MARKET LANDSCAPE
5.18.1 LENGTH OF STAY AND COST DRIVERS OF BURN TREATMENT
5.18.1.1 Length of stay
5.18.1.2 Cost drivers of burn treatment
5.18.2 CPT AND DRG CODES FOR BURNS
5.18.3 INSURANCE POLICIES & COVERAGE
5.18.4 TREATMENT COST BY HOSPITALS
5.18.5 REIMBURSEMENT SCENARIO IN US
5.18.5.1 Changes in reimbursement scenario in US
5.19 TRUMP TARIFF IMPACT ON BURN CARE MARKET
5.19.1 INTRODUCTION
5.19.2 KEY TARIFF RATES

6 BURN CARE MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 ADVANCED BURN DRESSINGS
6.2.1 ALGINATE DRESSINGS
6.2.1.1 Ability to absorb exudates and promote faster healing to boost adoption
6.2.2 COLLAGEN DRESSINGS
6.2.2.1 Increasing regulatory approvals for collagen-based products in burn care to fuel growth
6.2.3 HYDROGEL DRESSINGS
6.2.3.1 Advancements in hydrogel dressings to drive market adoption by improving burn care efficiency
6.2.4 HYDROCOLLOID DRESSINGS
6.2.4.1 Ability to promote healing by providing protective barrier to burn wounds to drive market
6.2.5 WOUND CONTACT LAYERS
6.2.5.1 Ability to protect wound bed from bacterial growth while promoting healing to propel growth
6.2.6 FILM DRESSINGS
6.2.6.1 Non-absorbable nature of film dressings to limit adoption
6.2.7 FOAM DRESSINGS
6.2.7.1 High absorbency and ongoing advancements in antibacterial technology in foam dressings to contribute to growth
6.2.8 OTHER ADVANCED BURN DRESSINGS
6.3 BURN WOUND THERAPY DEVICES
6.3.1 BURN WOUND ASSESSMENT DEVICES
6.3.1.1 Improved precision in burn evaluation and treatment planning to increase adoption
6.3.1.2 Key players providing burn wound assessment devices
6.3.1.3 AI and machine learning integration in burn wound assessment
6.3.1.4 Core technologies in burn wound assessment
6.3.1.4.1 Laser doppler imaging (LDI)
6.3.1.4.2 Thermal imaging & fluorescence imaging
6.3.1.5 Emerging innovations in burn wound assessment
6.3.2 NPWT DEVICES
6.3.2.1 Growing adoption of single-use NPWT devices in home care settings to drive market
6.3.3 OTHER BURN WOUND THERAPY DEVICES
6.4 BIOLOGICS
6.4.1 INCREASING ADOPTION OF INNOVATIVE SKIN GRAFTS FOR EFFECTIVE MANAGEMENT OF SEVERE BURN WOUNDS TO DRIVE MARKET GROWTH
6.5 TRADITIONAL BURN CARE PRODUCTS
6.5.1 TAPES
6.5.1.1 Increased use of tapes for burn wound coverage to fuel market growth
6.5.2 DRESSINGS
6.5.2.1 Widespread use of basic dry dressings in minor burns to fuel market growth
6.6 OTHER BURN CARE PRODUCTS

7 BURN CARE MARKET, BY BURN DEGREE
7.1 INTRODUCTION
7.2 SECOND-DEGREE BURNS (PARTIAL-THICKNESS BURNS)
7.2.1 ENHANCED BURN CARE TECHNOLOGIES TO ACCELERATE HEALING OUTCOMES FOR PARTIAL-THICKNESS BURNS
7.3 FIRST-DEGREE BURNS (MINOR BURNS)
7.3.1 HIGH PREVALENCE OF FIRST-DEGREE BURNS TO SIGNIFICANTLY CONTRIBUTE TO MARKET GROWTH
7.4 THIRD-DEGREE BURNS (FULL-THICKNESS BURNS)
7.4.1 NEED FOR SPECIALIZED TREATMENTS FOR THIRD-DEGREE BURNS TO FUEL MARKET EXPANSION

8 BURN CARE MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS
8.2.1 INPATIENT FACILITIES
8.2.1.1 Increasing number of hospital admissions to drive market growth
8.2.2 OUTPATIENT FACILITIES
8.2.2.1 Cost-efficiency of outpatient settings to boost market growth
8.3 PHYSICIAN CLINICS & AMBULATORY CARE SETTINGS
8.3.1 LOWER COSTS AND SHORTER PATIENT STAYS TO PROPEL GROWTH
8.4 HOME CARE SETTINGS
8.4.1 TECHNOLOGICAL INNOVATION AND INCREASED PRODUCT AVAILABILITY TO BOOST MARKET GROWTH
8.5 BURN TREATMENT CENTERS
8.5.1 RISING BURN PATIENT NUMBERS TO FUEL GROWTH OF BURN TREATMENT CENTERS
8.6 OTHER END USERS

9 BURN CARE MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
9.2.2 US
9.2.2.1 Rising incidence of burns and continuous product innovation to propel market growth
9.2.3 CANADA
9.2.3.1 Increase in fire incidents to drive growth in burn care market in Canada
9.3 EUROPE
9.3.1 EUROPE: MACROECONOMIC OUTLOOK
9.3.2 UK
9.3.2.1 Rising burn injuries and strong R&D investments to drive market growth
9.3.3 GERMANY
9.3.3.1 High healthcare expenditure and rising incidence of burn injuries to drive significant growth
9.3.4 FRANCE
9.3.4.1 Ongoing advancements in burn care technology to fuel market growth
9.3.5 ITALY
9.3.5.1 Improvements in quality and accessibility of medical care to drive market growth
9.3.6 SPAIN
9.3.6.1 Growing elderly population to boost demand for burn care products in Spain
9.3.7 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
9.4.2 CHINA
9.4.2.1 Growing elderly population and improved healthcare infrastructure to fuel market growth
9.4.3 JAPAN
9.4.3.1 Increasing regulatory approvals for burn care products to drive market growth
9.4.4 INDIA
9.4.4.1 High prevalence of burns and healthcare improvements to fuel market growth
9.4.5 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 IMPROVED ACCESS TO HEALTHCARE TO DRIVE DEMAND FOR BURN CARE PRODUCTS
9.5.2 LATIN AMERICA: MACROECONOMIC OUTLOOK
9.6 MIDDLE EAST & AFRICA
9.6.1 INCREASING HEALTHCARE INVESTMENTS TO SUPPORT MARKET GROWTH
9.6.2 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK

10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BURN CARE MARKET
10.3 REVENUE ANALYSIS, 2022-2024
10.4 MARKET SHARE ANALYSIS, 2024
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
10.5.5.1 Company footprint
10.5.5.2 Region footprint
10.5.5.3 Product footprint
10.5.5.4 Advanced burn care dressings footprint
10.5.5.5 Burn degree footprint
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
10.6.5.1 Detailed list of key startups/SMEs
10.6.5.2 Competitive benchmarking of startups/SMEs
10.7 COMPANY VALUATION & FINANCIAL METRICS
10.8 BRAND/PRODUCT COMPARISON
10.9 COMPETITIVE SCENARIO
10.9.1 PRODUCT LAUNCHES & APPROVALS
10.9.2 DEALS
10.9.3 EXPANSIONS
10.9.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES
11.1 KEY PLAYERS
11.1.1 SMITH+NEPHEW
11.1.1.1 Business overview
11.1.1.2 Products offered
11.1.1.3 Recent developments
11.1.1.3.1 Product launches
11.1.1.3.2 Deals
11.1.1.3.3 Expansions
11.1.1.3.4 Other developments
11.1.1.4 MnM view
11.1.1.4.1 Right to win
11.1.1.4.2 Strategic choices
11.1.1.4.3 Weaknesses & competitive threats
11.1.2 MOLNLYCKE HEALTH CARE AB
11.1.2.1 Business overview
11.1.2.2 Products offered
11.1.2.3 Recent developments
11.1.2.3.1 Deals
11.1.2.4 MnM view
11.1.2.4.1 Right to win
11.1.2.4.2 Strategic choices
11.1.2.4.3 Weaknesses & competitive threats
11.1.3 CARDINAL HEALTH INC.
11.1.3.1 Business overview
11.1.3.2 Products offered
11.1.3.3 Recent developments
11.1.3.3.1 Expansions
11.1.3.4 MnM view
11.1.3.4.1 Right to win
11.1.3.4.2 Strategic choices
11.1.3.4.3 Weaknesses & competitive threats
11.1.4 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
11.1.4.1 Business overview
11.1.4.2 Products offered
11.1.4.3 Recent developments
11.1.4.3.1 Product launches
11.1.4.3.2 Deals
11.1.4.4 MnM view
11.1.4.4.1 Right to win
11.1.4.4.2 Strategic choices
11.1.4.4.3 Weaknesses & competitive threats
11.1.5 CONVATEC GROUP PLC
11.1.5.1 Business overview
11.1.5.2 Products offered
11.1.5.3 Recent developments
11.1.5.3.1 Product approvals
11.1.5.3.2 Deals
11.1.5.4 MnM view
11.1.5.4.1 Right to win
11.1.5.4.2 Strategic choices
11.1.5.4.3 Weaknesses & competitive threats
11.1.6 COLOPLAST GROUP
11.1.6.1 Business overview
11.1.6.2 Products offered
11.1.6.3 Recent developments
11.1.6.3.1 Deals
11.1.7 SOLVENTUM CORPORATION
11.1.7.1 Business overview
11.1.7.2 Products offered
11.1.7.3 Recent developments
11.1.7.3.1 Other developments
11.1.8 B. BRAUN SE
11.1.8.1 Business overview
11.1.8.2 Products offered
11.1.9 ESSITY AKTIEBOLAG
11.1.9.1 Business overview
11.1.9.2 Products offered
11.1.9.3 Recent developments
11.1.9.3.1 Deals
11.1.10 PAUL HARTMANN AG
11.1.10.1 Business overview
11.1.10.2 Products offered
11.1.11 MATIV HOLDINGS, INC.
11.1.11.1 Business overview
11.1.11.2 Products offered
11.1.11.3 Recent developments
11.1.11.3.1 Deals
11.1.12 ADVANCED MEDICAL SOLUTIONS GROUP PLC
11.1.12.1 Business overview
11.1.12.2 Products offered
11.1.13 ORGANOGENESIS HOLDINGS INC.
11.1.13.1 Business overview
11.1.13.2 Products offered
11.1.14 VERICEL CORPORATION
11.1.14.1 Business overview
11.1.14.2 Products offered
11.1.14.3 Recent developments
11.1.14.3.1 Product launches & approvals
11.1.15 MIMEDX GROUP, INC.
11.1.15.1 Business overview
11.1.15.2 Products offered
11.1.15.3 Recent developments
11.1.15.3.1 Product launches
11.1.15.3.2 Deals
11.2 OTHER PLAYERS
11.2.1 DEROYAL INDUSTRIES, INC.
11.2.2 LOHMANN & RAUSCHER GMBH & CO. KG
11.2.3 MEDLINE INDUSTRIES, LP
11.2.4 MOOR INSTRUMENTS LIMITED
11.2.5 URGO GROUP
11.2.6 MISSNER & MISSNER LTDA
11.2.7 MIMOSA DIAGNOSTICS
11.2.8 DERMARITE INDUSTRIES, LLC
11.2.9 FOCUS HEALTH GROUP
11.2.10 AXIO BIOSOLUTIONS PVT. LTD.
11.2.11 MIL LABORATORIES PVT. LTD.
11.2.12 HUBEI HENDRY MEDICAL APPLIANCE CO., LTD.

12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS